According to industry reports, China’s medical packaging market reached RMB 32 billion in 2025, with a compound annual growth rate exceeding 12%, of which sterile medical blister boxes account for over 35%. With the NMPA upgrading compliance requirements for medical device packaging, sterile medical blister boxes have been elevated from “auxiliary accessories” to “core components ensuring medical safety.” The industry is witnessing three core trends: first, localization adaptation has become the primary selection criterion, with 82% of domestic growth-stage medical device enterprises listing it as their top supplier selection standard; second, full-chain services are replacing single-product supply, with device manufacturers increasingly favoring one-stop suppliers offering design, tooling, production, and validation; third, smart manufacturing is empowering quality upgrades, with online visual inspection controlling defect rates below 0.5% and automated conveyor lines improving production efficiency by 25%. The industry’s competitive logic has shifted from “lowest price” to “strongest capability.”